GlaxoSmithKline recalls Ventolin Diskus inhalers

Photo source: Health Canada

The inhalers may not deliver the intended dose

GlaxoSmithKline is recalling one lot of Ventolin Diskus inhalers that may not deliver the intended dose.

Ventolin Diskus is a prescription drug used in adults and children 4 years or older to relieve and prevent bronchospasm due to asthma, chronic bronchitis and other chronic lung disorders.

Bronchospasm is a sudden worsening of shortness of breath and wheezing.

Individuals who do not receive the intended dose may not be aware that the dose was not delivered. Their symptoms (cough, wheeze, breathlessness or tight chest) may get worse over time and they can suffer serious health consequences, including a potentially life-threatening asthma attack.

The following product, sold throughout Canada, is being recalled:

  • Ventolin Diskus (200 mcg salbutamol per blister (60 Dose) (DIN 02243115)) Lot 786G, Expiry 05 2019

What to do

Customers who purchased the recalled product should return it to the pharmacy where purchased for a replacement.

Consumers with questions or concerns may contact GlaxoSmithKline (GSK) via Stericycle (which is managing the recall on GSK’s behalf) at 1-855-215-5956.

Find a Medical Alert System partner near you.